ISPOR held a number of sessions at its 22nd Annual International Conference in Boston, MA, USA that focused on the health care systems from different countries.
ISPOR held an afternoon session at its 22nd Annual International Meeting in Boston, MA, USA that explored the use of real-world evidence to help inform health policies for medical devices.
ISPOR recognized honorees of the ISPOR Awards Program at its 22nd Annual International Meeting in Boston, MA, USA this week. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in HEOR.
ISPOR hosted a morning session at its 22nd Annual International Meeting in Boston, MA, USA that examined cost-effectiveness models for innovative oncology treatments.
ISPOR hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the issue of developing and paying for gene therapies.
ISPOR held its second plenary session this morning at its 22nd Annual International Meeting in Boston, MA, USA. The plenary, Social Network Interventions and Population Health, highlighted the research of Nicholas A. Christakis, MD, PhD, MPH.
ISPOR hosted a session this morning at its 22nd Annual International Meeting in Boston, MA, USA that examined the relationship between cost effectiveness and affordability of health care therapies.
ISPOR held two scientific sessions on value assessment frameworks this afternoon at its 22nd Annual International Meeting in Boston, MA, USA.
ISPOR opened its 22nd Annual International Meeting in Boston, MA, USA this morning with its first plenary session, Where Is US Health Policy Going?.
ISPOR hosted a session at its 22nd Annual International Meeting that explored what methods researchers and health technology assessors should employ to best capture the patient voice in HEOR research.
ISPOR and ISPE have joined forces to collaborate on a Special Task Force on real-world evidence in regulatory decision making. This initiative was the focus of an invited issue panel this morning at the ISPOR 22nd Annual International Meeting in Boston, MA, USA.
ISPOR held several sessions at its 22nd Annual International Meeting in Boston, MA, USA this afternoon that discussed regulatory and health policy implications of the 21st Century Cures Act.
ISPOR hosted a session that explored the economic impact of Medicare directly negotiating drug prices for enrollees. The session was held this afternoon at ISPOR’s 22nd Annual International Meeting in Boston, MA, USA.
ISPOR recognized the Best Podium and Poster Presentation Awardees at its 22nd Annual International Meeting today in Boston, MA, USA.
ISPOR announced confirmation of the scientific sessions for its upcoming 22nd Annual International Meeting in Boston, MA, USA on May 20-24, 2017. The conference is expected to draw more than 4,000 health care stakeholders including policy makers, payers, thought leaders, researchers, academicians, decision makers, and patient representatives.
Value in Health, the official journal of ISPOR, announced today the publication of new research reviewing and comparing the policies of 6 European health technology assessment (HTA) agencies on incorporating real-world data into health technology assessments.
Value in Health, the official journal of the ISPOR, announced today the publication of new research indicating that testing for variants in 7 cancer-associated genes (versus the usual process of testing in just 2 genes) followed by risk-reduction management could cost-effectively improve life expectancy for women at risk of hereditary breast cancer.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced the recipients of its 2017 Scientific Achievement and Leadership Awards.
ISPOR announced the publication of original research estimating the costs of cancer care in children and adolescents in the March issue of Value in Health.
ISPOR announced the publication of suggested guidelines on establishing research partnerships with patients in the March 2017 issue of Value in Health. The report of these novel recommendations for outcomes researchers is entitled, "Emerging Guidelines for Patient Engagement in Research."
ISPOR published a new task force report, "Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force,” in the March 2017 issue of Value in Health. This new task force report provides health care researchers and decision makers with an introductory overview of this important methodology.
ISPOR announced plenary sessions and speakers for its 22nd Annual International Meeting that will be held May 20-24, 2017 in Boston, MA, USA. The conference will focus on significant changes in health care and policy with the timely theme, "Evidence and Value in a Time of Social and Policy Change."
ISPOR announced the publication of a special theme issue of its flagship journal, Value in Health, devoted to methodological, process, and ethical considerations of value assessment frameworks.
ISPOR published a new Task Force Report, “Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report,” in the January 2017 issue of Value in Health.
ISPOR published a new Task Force Report, “Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force,” in the January 2017 issue of Value in Health.
ISPOR will be offering a new, complimentary educational webinar, "Introduction to Health Economics and Outcomes Research (HEOR): What Is It and How Can We Use It to Improve Decision Making?," on Wednesday, February 22, 2017 from 12:00 PM–1:00 PM EST.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has submitted comments in response to the European Commission’s request for public consultation regarding the issue of European Union (EU) cooperation on health technology assessment (HTA).
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) recently announced the appointment of three leadership positions in its Global Networks Division.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the publication of a series of articles exploring trends in policy and methods regarding the country-specific provision of universal health care coverage. This special themed section, "Economics of Making Choices on the Journey to Universal Health Care Coverage," was published in the December issue of Value in Health.
The International Society for Pharmacoeconomics and Outcomes Research announced that its regional health economics and outcomes research (HEOR) publication, Value in Health Regional Issues, was recently accepted for indexing in MEDLINE®/PubMed®.
The International Society for Pharmacoeconomics and Outcomes Research announced its upcoming health economics and outcomes research (HEOR) in-person training programs scheduled for early 2017.
The International Society for Pharmacoeconomics and Outcomes Research recently concluded its 19th Annual European Congress in Vienna, Austria. More than 4,700 delegates—stakeholders from all sectors of health care, including health ministries and government offices, health technology assessment bodies, public and private payers, researchers and academics, patients and patient advocates—representing 89 countries convened on 29 October through 2 November 2016 to discuss access to medical innovations in Europe.
The International Society for Pharmacoeconomics and Outcomes Research recognized the Best Podium Presentation and Best Poster Presentation Awardees at its 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research CEO and Executive Director Nancy Berg has been named the winner of a Silver Stevie® Award in the Female Executive of the Year category in the 13th annual Stevie Awards for Women in Business.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced today the launch of its New Professionals Network. The new membership category is designed to serve the unique needs of future leaders in the field of health economics and outcomes research (HEOR).
ISPOR recognized recipients at its 19th Annual European Congress. The ISPOR Awards Program is designed to foster and recognize excellence and outstanding technical achievement in health economics and outcomes research (HEOR).
ISPOR held an issue panel entitled, "Using Observational (Real-World) Data in Health Technology Assessment: Route to Confusion or Better Decisions?" The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) hosted its third plenary session, "How to Control Costs and Improve Access to Medicines: Lessons from the InterQuality Project," at the Society’s 19th Annual European Congress in Vienna, Austria.
ISPOR held an issue panel entitled, "Should Health Technology Assessment Guidelines Recommend Inclusion of Future Medical Costs?," at the Society’s 19th Annual European Congress in Vienna, Austria.
ISPOR hosted an issue panel entitled, "Real World Evidence to Support Value Proposition and Reimbursement at Launch: The Aspirational Meets the Impractical?,'" at the Society’s 19th Annual European Congress in Vienna, Austria.
ISPOR offered an issue panel, "Valuing Transformative Medicines in Rare Diseases: Methods and Madness," at the Society’s 19th Annual European Congress in Vienna, Austria.
ISPOR held an issue panel this afternoon entitled, Emerging US Value Frameworks: Are There Lessons From – Or For – Europe? The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a session this afternoon entitled, "Adaptive Pathways and Patient Access: Pushing Payer Boundaries or Facilitating New Payment Models?" at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its second plenary session, "Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability," this morning at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning on Incentivizing Research Into the Effectiveness of Medical Devices at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this morning entitled, "The Potential and Pitfalls of Using Multi-Criteria Decision Analysis to Support Health Technology Assessment." The session took place at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) led a session this afternoon entitled, "From Testimonials to Qualitative Research Embedded in Clinical Trials: How Do Health Technology Assessment Bodies Consider the Voice of Rare Disease Patients When Granting Access to Orphan Drugs?" The discussion took place at the Society’s 19th Annual European Congress—in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a workshop this afternoon on "New Approaches to Survival Modeling in Oncology" at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) facilitated a discussion on National Health Technology Assessment (HTA) Process and European Cooperation on HTA: Fit for Purpose? this morning at the Society’s 19th Annual European Congress in Vienna, Austria.
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) opened its 19th Annual European Congress in Vienna, Austria this morning with the first plenary session, "What Synergies Could Be Created Between Regulatory and Health Technology Assessments?"
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right